Assessment of patient and provider attitudes towards therapeutic drug monitoring to improve medication adherence in low-income patients with hypertension: a qualitative study.
Assessment of patient and provider attitudes towards therapeutic drug monitoring to improve medication adherence in low-income patients with hypertension: a qualitative study.
复制标题
评估患者和医务人员对治疗药物监测的态度,以提高低收入高血压患者的服药依从性:一项定性研究。
DOI:
10.1136/bmjopen-2020-039940
复制
发表时间:
2020-11-27
期刊:
影响因子:
2.9
通讯作者:
Vongpatanasin W
中科院分区:
文献类型:
--
作者:
Schesing KB;Chia R;Elwood B;Halm EA;Lee SJC;Lodhi H;Wu B;Sharma S;Smith SA;Jarrett RB;Das SR;Vongpatanasin W
Previous studies have implicated therapeutic drug monitoring (TDM), by measuring serum or urine drug levels, as a highly reliable technique for detecting medication non-adherence but the attitudes of patients and physicians toward TDM have not been evaluated previously. Accordingly, we solicited input from patients with uncontrolled hypertension and their physicians about their views on TDM. Prospective analysis of responses to a set of questions during semistructured interviews. Outpatient clinics in an integrated health system which provides care for a low-income, uninsured population. Patients with uncontrolled hypertension with either systolic blood pressure of at least 130 mm Hg or diastolic blood pressure of at least 80 mm Hg despite antihypertensive drugs and providers in the general cardiology and internal medicine clinics. Attitudes towards TDM and the potential impact on physician–patient relationship. We interviewed 11 patients and 10 providers and discussed the findings with 13 community advisory panel (CAP) members. Of the patients interviewed, 91% (10 of 11) and all 10 providers thought TDM was a good idea and should be used regularly to better understand the reasons for poorly controlled hypertension. However, 63% (7 of 11) of patients and 20% of providers expressed reservations that TDM could negatively impact the physician–patient relationship. Despite some concerns, the majority of patients, providers and CAP members believed that if test results are communicated without blaming patients, the potential benefits of TDM in identifying suboptimal adherence and eliciting barriers to adherence outweighed the risks. The idea of TDM is well accepted by patients and their providers. TDM information if delivered in a non-judgmental manner, to encourage an honest conversation between patients and physicians, has the potential to reduce patient–physician communication obstacles and to identify barriers to adherence which, when overcome, can improve health outcomes.
登录
查看更多内容
影响因子:
5.4
作者:
Zeller, Andreas;Taegtmeyer, Anne;Tschudi, Peter
通讯作者:
Tschudi, Peter
影响因子:
105.7
作者:
Vrijens, Bernard;Vincze, Gabor;Burnier, Michel
通讯作者:
Burnier, Michel
影响因子:
3.2
作者:
Creswell, JW;Miller, DL
通讯作者:
Miller, DL
影响因子:
3
作者:
Feyz, Lida;Bahmany, Soma;Versmissen, Jorie
通讯作者:
Versmissen, Jorie
DOI:
10.1111/jch.12570
发表时间:
2015-09
期刊:
Journal of clinical hypertension (Greenwich, Conn.)
影响因子:
--
作者:
Velasco A;Chung O;Raza F;Pandey A;Brinker S;Arbique D;Price A;Lotan Y;Das SR;Vongpatanasin W
通讯作者:
Vongpatanasin W